EU funded CAMINEMS project combines three emerging technologies – nanotechnology, optical technologies, and microfluidics

Some 90% of cancer deaths are caused by metastases that are most often caused by circulating tumour cells (CTCs) which escape from the primary tumour. Being able to capture and study CTCs would be of enormous benefit for research, to help understand the cells’ metabolism, how they colonise other organs and how they may respond to either existing or future drugs. Existing technologies, however, are unable to do this. Work is now underway to develop a second-generation, pre-industrial prototype of CTCs device. Read more about the project here.